Marker Therapeutics, Inc. (MRKR)
1.27
+0.02
(+1.60%)
USD |
NASDAQ |
Sep 03, 11:14
Marker Therapeutics Cash from Operations (Annual) : -12.01M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -12.01M |
| December 31, 2024 | -10.91M |
| December 31, 2023 | -16.44M |
| December 31, 2022 | -26.97M |
| December 31, 2021 | -27.28M |
| December 31, 2020 | -18.86M |
| December 31, 2019 | -18.28M |
| December 31, 2018 | -14.48M |
| December 31, 2017 | -8.439M |
| December 31, 2016 | -6.510M |
| December 31, 2015 | -4.343M |
| December 31, 2014 | -2.187M |
| December 31, 2013 | -0.771M |
| December 31, 2012 | -1.745M |
| Date | Value |
|---|---|
| December 31, 2011 | -1.310M |
| December 31, 2010 | -0.925M |
| December 31, 2009 | -1.122M |
| December 31, 2008 | -0.7144M |
| December 31, 2007 | -1.226M |
| December 31, 2006 | -1.186M |
| December 31, 2005 | -1.165M |
| December 31, 2004 | -1.215M |
| December 31, 2003 | -2.591M |
| December 31, 2002 | -1.407M |
| December 31, 2001 | 0.0024M |
| December 31, 2000 | |
| December 31, 1999 | -0.8152M |
| December 31, 1998 | -0.2414M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Krystal Biotech, Inc. | 200.86M |
| Ironwood Pharmaceuticals, Inc. | 127.04M |
| SELLAS Life Sciences Group, Inc. | -28.39M |
| Rezolute, Inc. | -69.08M |
| ADMA Biologics, Inc. | 50.40M |